Skip to content

KalVista Pharmaceuticals, Inc.: filings

Every KalVista Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 44 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-05-14fiscal Q1 202646870001193125-26-223976
10-Q2025-11-10fiscal Q3 2025461270001193125-25-274442
10-Q2025-09-11fiscal Q1 202642850001193125-25-200757
10-K2025-07-10fiscal FY 202545870000950170-25-095011
10-Q2025-03-12fiscal Q3 2025381110000950170-25-037995
10-Q2024-12-05fiscal Q2 202534970000950170-24-133673
10-Q2024-09-05fiscal Q1 202533680000950170-24-103981
10-K2024-07-11fiscal FY 2024411050000950170-24-082965
10-Q2024-03-11fiscal Q3 2024341010000950170-24-029314
10-Q2023-12-07fiscal Q2 202433960000950170-23-068801
10-Q2023-09-07fiscal Q1 202433680000950170-23-047008
10-K2023-07-10fiscal FY 2023411050000950170-23-032298
10-Q2023-03-09fiscal Q3 2023341010000950170-23-007020
10-Q2022-12-08fiscal Q2 202333960000950170-22-026230
10-Q2022-09-08fiscal Q1 202333680000950170-22-018239
10-K2022-07-07fiscal FY 2022421060000950170-22-012521
10-Q2022-03-10fiscal Q3 202230850000950170-22-003361
10-Q2021-12-09fiscal Q2 202229800000950170-21-005116
10-Q2021-09-09fiscal Q1 202230610001564590-21-047480
10-K2021-07-13fiscal FY 202137930001564590-21-036441
10-Q2021-03-11fiscal Q3 202132890001564590-21-012500
10-Q2020-12-10fiscal Q2 202132840001564590-20-056718
10-Q2020-09-14fiscal Q1 202132630001564590-20-043418
10-K2020-07-01fiscal FY 2020381160001564590-20-031501
10-Q2020-03-10fiscal Q3 202034940001564590-20-009752
10-Q2019-12-03fiscal Q2 202034890001564590-19-045155
10-Q2019-09-09fiscal Q1 202034690001564590-19-034364
10-K2019-07-16fiscal FY 2019351140001564590-19-025009
10-Q2019-03-14fiscal Q3 201931920001564590-19-007827
10-Q2018-12-14fiscal Q2 201931890001564590-18-030939
10-Q2018-09-14fiscal Q1 201931620001564590-18-023147
10-K2018-07-30fiscal FY 2018331120001564590-18-017915
10-Q2018-03-16fiscal Q3 201826720001564590-18-006049
10-Q2017-12-14fiscal Q2 201825690001564590-17-024944
10-Q2017-09-14fiscal Q1 201823480001564590-17-018672
10-K2017-07-27fiscal FY 201728900001564590-17-014286
10-Q2017-03-16fiscal Q3 201625690001564590-17-004659
10-Q2016-11-08fiscal Q3 201626620001564590-16-028340
10-Q2016-08-12fiscal Q2 201626620001564590-16-024180
10-Q2016-05-12fiscal Q1 201625510001564590-16-019244
10-K2016-03-30fiscal FY 201530930001564590-16-015646
10-Q2015-11-12fiscal Q3 201526670001564590-15-010631
10-Q2015-08-13fiscal Q2 201527720001564590-15-007264
10-Q2015-05-21fiscal Q1 201531620001193125-15-196884

Inspect the source

Entity
KalVista Pharmaceuticals, Inc. / CIK 0001348911
Captured
2026-09-21T17:18:41.780Z
SEC response SHA-256
c81d143cb84b0ac042c4c8cf17a684b6c700ad188b77cffd256522977b23f9b6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001348911.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))